NO983984L - Disintegrin-metalloprotease samt anvendelse derav - Google Patents
Disintegrin-metalloprotease samt anvendelse deravInfo
- Publication number
- NO983984L NO983984L NO983984A NO983984A NO983984L NO 983984 L NO983984 L NO 983984L NO 983984 A NO983984 A NO 983984A NO 983984 A NO983984 A NO 983984A NO 983984 L NO983984 L NO 983984L
- Authority
- NO
- Norway
- Prior art keywords
- disintegrin
- protein
- binding
- expression vector
- recombinant expression
- Prior art date
Links
- 101800001224 Disintegrin Proteins 0.000 title abstract 6
- 102000005741 Metalloproteases Human genes 0.000 title abstract 3
- 108010006035 Metalloproteases Proteins 0.000 title abstract 3
- 102000004169 proteins and genes Human genes 0.000 abstract 4
- 108090000623 proteins and genes Proteins 0.000 abstract 4
- 150000001875 compounds Chemical class 0.000 abstract 2
- 239000013604 expression vector Substances 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 238000003259 recombinant expression Methods 0.000 abstract 2
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 238000000338 in vitro Methods 0.000 abstract 1
- 238000001727 in vivo Methods 0.000 abstract 1
- 201000008482 osteoarthritis Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
- C07H21/04—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6489—Metalloendopeptidases (3.4.24)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
- G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
- G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
- G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
- G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
- G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
- G01N2333/96486—Metalloendopeptidases (3.4.24)
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Animal Behavior & Ethology (AREA)
- Physics & Mathematics (AREA)
- Public Health (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Pathology (AREA)
- Rheumatology (AREA)
- Veterinary Medicine (AREA)
- Hematology (AREA)
- Cell Biology (AREA)
- Endocrinology (AREA)
- Pain & Pain Management (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Diabetes (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US1267996P | 1996-03-01 | 1996-03-01 | |
| PCT/US1997/003217 WO1997031931A1 (en) | 1996-03-01 | 1997-02-28 | A novel disintegrin metalloprotease and methods of use |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO983984D0 NO983984D0 (no) | 1998-08-28 |
| NO983984L true NO983984L (no) | 1998-11-02 |
Family
ID=21756171
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO983984A NO983984L (no) | 1996-03-01 | 1998-08-28 | Disintegrin-metalloprotease samt anvendelse derav |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP0888375A4 (de) |
| JP (1) | JPH11506023A (de) |
| KR (1) | KR19990087444A (de) |
| AU (1) | AU2061797A (de) |
| CA (1) | CA2247827A1 (de) |
| NO (1) | NO983984L (de) |
| NZ (1) | NZ331844A (de) |
| WO (1) | WO1997031931A1 (de) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6255064B1 (en) | 1996-03-01 | 2001-07-03 | The Procter & Gamble Company | Disintegrin metalloprotease and its use |
| US5935792A (en) * | 1996-08-29 | 1999-08-10 | The Regents Of The University Of California | KUZ, a novel family of metalloproteases |
| WO1998037092A2 (en) * | 1997-02-25 | 1998-08-27 | The Procter & Gamble Company | Use of a novel disintegrin metalloprotease |
| US6436629B1 (en) | 2000-10-27 | 2002-08-20 | The Regents Of The University Of California | Modulating angiogenesis |
| US6294368B1 (en) * | 2001-03-22 | 2001-09-25 | Applera Corporation | Isolated human metalloprotease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof |
| CA2474908A1 (en) * | 2002-01-31 | 2003-08-07 | Wyeth | Aggrecanase molecules |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5935792A (en) * | 1996-08-29 | 1999-08-10 | The Regents Of The University Of California | KUZ, a novel family of metalloproteases |
-
1997
- 1997-02-28 KR KR1019980706866A patent/KR19990087444A/ko not_active Ceased
- 1997-02-28 WO PCT/US1997/003217 patent/WO1997031931A1/en not_active Ceased
- 1997-02-28 EP EP97908799A patent/EP0888375A4/de not_active Withdrawn
- 1997-02-28 NZ NZ331844A patent/NZ331844A/en unknown
- 1997-02-28 CA CA002247827A patent/CA2247827A1/en not_active Abandoned
- 1997-02-28 AU AU20617/97A patent/AU2061797A/en not_active Abandoned
- 1997-02-28 JP JP9531177A patent/JPH11506023A/ja active Pending
-
1998
- 1998-08-28 NO NO983984A patent/NO983984L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP0888375A1 (de) | 1999-01-07 |
| EP0888375A4 (de) | 2001-04-11 |
| JPH11506023A (ja) | 1999-06-02 |
| NO983984D0 (no) | 1998-08-28 |
| CA2247827A1 (en) | 1997-09-04 |
| WO1997031931A1 (en) | 1997-09-04 |
| KR19990087444A (ko) | 1999-12-27 |
| AU2061797A (en) | 1997-09-16 |
| NZ331844A (en) | 2000-06-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK104093D0 (da) | Fremgangsmaade til bestemmelse af collagen-fragmenter i legemsvaesker, test-kit og midler til udoevelse af fremgangsmaaden og anvendelse af fremgangsmaaden til diagnosticering af lidelser associeret til collagen-metabolismen | |
| WO1999042839A3 (en) | Treating cancer | |
| NO963371L (no) | Hematopoietisk protein samt materialer og fremgangsmåter for fremstilling av det | |
| DE60140773D1 (de) | Polypeptide zur Bindung an das B-Lymphozyten-stimulatorische Protein (BLyS) | |
| DK0953046T3 (da) | Human hæmatopoietisk stam- og progenitorcelleantigen og fremgangsmåder til anvendelse af dette | |
| ATE230487T1 (de) | Verfahren zur frühen diagnose von carcinomen | |
| DE69940969D1 (de) | Detektion von neoplasien durch speichelanalyse | |
| WO2002008767A3 (en) | Methods and kits for sequencing polypeptides | |
| ATE258310T1 (de) | Testverfahren für collagenpeptid | |
| FR2816410B1 (fr) | Necessaire de detection de la proteine esm-1 et procede de detection mettant en oeuvre ledit necessaire | |
| JPH02500022U (de) | ||
| AU3623197A (en) | Peptide reagent for the detection of human cytomegalovirus (cmv) | |
| FR2735238B1 (fr) | Utilisation d'un complexe phycobiliproteine-peptide de liaison en tant que traceur fluorescent | |
| NO924912D0 (no) | Fremgangsmaate ved paavisning av analyttvarianter, samt sett for utfoerelse av fremgangsmaaten | |
| GR3018371T3 (en) | Method for identifying or determining proteins and applications therefor. | |
| NO962084L (no) | DNA sekvens som koder for en BMP reseptor | |
| NO983984L (no) | Disintegrin-metalloprotease samt anvendelse derav | |
| AU7110796A (en) | Borate storage buffer and sample diluent | |
| ES8501630A1 (es) | Un metodo para detectar o vigilar el estado de una condicion patologica humana que implica proteina de tejido conjuntivo. | |
| IL144129A0 (en) | Methods and kits for sequencing polypeptides | |
| AU2174002A (en) | Method for analyzing proteins | |
| NO994056L (no) | Anvendelse av disintegrin metalloprotease samt mutanter og fragmenter derav | |
| AP2368A (en) | Novel expression vectors and uses thereof. | |
| Maruyama et al. | Hemoglobins of the tadpole of the bullfrog, Rana catesbeiana. Amino acid sequence of the alpha chain of a major component. | |
| DK0973887T3 (da) | Porcin leptin-protein, nukleinsyresekvenser, som koder herfor, og anvendelser heraf |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |